罕见病药物氨己烯酸片贵吗价格多少

Vigabatrin, also known as Sabril, is a drug used to treat epilepsy and infantile spasms. It was developed in the 1980s and approved for treatment in the UK in 1989. On August 21, 2009, the U.S. FDA approved Sabril as a monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjunctive (additional) treatment (CPS) for adult patients with refractory complex partial epilepsy. On January 16, 2019, the FDA approved the launch of a generic version of vigabatrin.

Are the rare disease drug vigabatrin tablets expensive? How much does it cost? Medical Companion Travel has learned that the specifications of vigabatrin tablets produced by Sanofi in France are 500mg*100 tablets, and the price is around 1,500$. The price may change due to various factors such as exchange rates. Patients can consult the Medical Companion Travel Service for specific prices and formal purchasing methods.

The global average incidence of epilepsy is about 0.6%, one-third of which are refractory. Vigabatrin tablets are the first FDA-approved drug to treat infantile spasms. In the past two years, more and more children with TSC have effectively controlled epilepsy through the use of vigabatrin tablets, especially infantile spasms. Western countries even use vigabatrin tablets to prevent children with TSC who have not yet developed the disease once they develop brain electrical abnormalities.

The original drug has not been approved for marketing in my country, and there is currently no domestic price. It is understood that in March 2019, Yuanda Pharmaceutical independently developed vigabatrin tablets for refractory partial epilepsy and infantile spasms, and was included in the priority review list. It is believed that in the near future, vigabatrin tablets will soon be launched in my country.

Recommended related hot articles: /newsDetail/83105.html